SpaceX Starship Explosion Sets Back Mars Mission
By Reuters | 19 Jun, 2025
The Starship explosion while on a test stand preparing for its tenth test flight is deemed a major anomaly by SpaceX, suggesting a likely delay in the planned Mars mission.
SpaceX's massive Starship spacecraft exploded into a dramatic fireball during testing in Texas late on Wednesday, the latest in a series of setbacks for billionaire Elon Musk’s Mars rocket program.
The explosion occurred around 11 p.m. local time while Starship was on a test stand at its Brownsville, Texas Starbase while preparing for the tenth test flight, SpaceX said in a post on Musk’s social-media platform X.
The company attributed it to a "major anomaly,” and said all personnel were safe.
“Preliminary data suggests that a nitrogen COPV in the payload bay failed below its proof pressure,” Musk said in a post on X, in a reference to a nitrogen gas storage unit known as a Composite Overwrapped Pressure Vessel. “If further investigation confirms that this is what happened, it is the first time ever for this design,” he continued.
SpaceX didn’t immediately respond to a request for further comment.
(Reporting by Jaspreet Singh in Bengaluru and Cassel Bryan-Low in London; Editing by Joe Brock and Aidan Lewis)
“Preliminary data suggests that a nitrogen COPV in the payload bay failed below its proof pressure,” Musk said in a post on X, in a reference to a nitrogen gas storage unit known as a Composite Overwrapped Pressure Vessel.
Recent Articles
- US Seizes Iranian Cargo Ship, Tehran Vows to Retaliate
- Asian Airlines See European Flight Demand Surge Amid Gulf Disruptions
- Carney Says Canada's Ties with the US Have Become a Weakness
- Iran Denies Peace Talks Scheduled As Announced by Trump
- Bedtime Story: Legend of the White Snake
- Tesla Expands Full Robotaxi Service to Dallas, Houston
- Improved Humanoid Robots Beat Humans in Beijing Half-Marathon,
- Google in Talks to Build AI Chips with Marvell
- Blue Origin Lands Reused New Glenn Rocket, Closing on SpaceX
- US Accelerates Access to Therapeutic Psychedelics
